Single-nucleotide variants in the IFNAR1 and IFNAR2 genes potentially affect the immune response, exacerbate, or attenuate the disease in the face of SARS-CoV-2 infection, in addition, could be new targets for therapies that limit the infection and the resulting inflammation. This evidence concerns the gene IFNAR1 and infection.